The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1α gene
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212 · cited 1×
“HIF-1 is a heterodimer HLH-PAS protein, which consists of , and subunits [ 6 ].”
BackgroundThe tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Hypoxia — a key regulatory factor in tumour growth
Harris, A. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc704 · Cited by 5,177 · cited 1×
“cancer cells may undergo a series of genetic and metabolic changes that allow them to survive and even proliferate [3, 4].”
BackgroundHIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
(2004) · New England Journal of Medicine · doi:10.1056/nejmoa031644 · Cited by 2,335
Hypoxia-inducible factor (HIF-1)α: its protein stability and biological functions
Lee, J.-W., Bae, S.-H., Jeong, J.-W., Kim, S.-H., & Kim, K.-W. (2004) · Experimental & Molecular Medicine · doi:10.1038/emm.2004.1 · Cited by 1,117
HIF-1 and human disease: one highly involved factor
Semenza, G. L. (2000) · Genes & Development · doi:10.1101/gad.14.16.1983 · Cited by 909 · cited 1×
“tance, and some apoptosis-related proteins [9, 10].”
(2002) · PubMed · Cited by 840
Expression of the gene encoding the proapoptotic Nip3 protein is induced by hypoxia
Bruick, R. K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.16.9082 · Cited by 773
Kamura, T., Sato, S., Iwai, K., Czyzyk-Krzeska, M., Conaway, R. C., & Conaway, J. W. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.190332597 · Cited by 653
(2003) · PubMed · Cited by 624
Teicher, B. A. (1994) · Cancer and Metastasis Reviews · doi:10.1007/bf00689633 · Cited by 563
Hypoxia-Inducible Factor 1α Is Essential for Cell Cycle Arrest during Hypoxia
Goda, N., Ryan, H. E., Khadivi, B., McNulty, W., Rickert, R. C., & Johnson, R. S. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.1.359-369.2003 · Cited by 520
Suppression of tumor growth through disruption of hypoxia-inducible transcription
Kung, A. L., Wang, S., Klco, J. M., Kaelin, W. G., & Livingston, D. M. (2000) · Nature Medicine · doi:10.1038/82146 · Cited by 501
YC-1: A Potential Anticancer Drug Targeting Hypoxia-Inducible Factor 1
Yeo, E.-J., Chun, Y.-S., Cho, Y.-S., Kim, J., Lee, J.-C., Kim, M.-S., & Park, J.-W. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.7.516 · Cited by 476
Uchida, T., Rossignol, F., Matthay, M. A., Mounier, R., Couette, S., Clottes, E., & Clerici, C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400461200 · Cited by 428
Erler, J. T., Cawthorne, C. J., Williams, K. J., Koritzinsky, M., Wouters, B. G., Wilson, C., Miller, C., Demonacos, C., Stratford, I. J., & Dive, C. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.7.2875-2889.2004 · Cited by 400
Tumor hypoxia: A target for selective cancer therapy
Kizaka‐Kondoh, S., Inoue, M., Harada, H., & Hiraoka, M. (2003) · Cancer Science · doi:10.1111/j.1349-7006.2003.tb01395.x · Cited by 352
The hypoxia-inducible factor-1α is a negative factor for tumor therapy
Unruh, A., Ressel, A., Mohamed, H. G., Johnson, R. S., Nadrowitz, R., Richter, E., Katschinski, D. M., & Wenger, R. H. (2003) · Oncogene · doi:10.1038/sj.onc.1206385 · Cited by 334
Wartenberg, M., Ling, F. C., Müschen, M., Klein, F., Acker, H., Gassmann, M., Petrat, K., Pütz, V., Hescheler, J., & Sauer, H. (2003) · The FASEB Journal · doi:10.1096/fj.02-0358fje · Cited by 287
Stoeltzing, O., McCarty, M. F., Wey, J. S., Fan, F., Liu, W., Belcheva, A., Bucana, C. D., Semenza, G. L., & Ellis, L. M. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh168 · Cited by 241
Molecular responses to hypoxia in tumor cells.
Kunz, M., & Ibrahim, S. M. (2003) · Molecular Cancer · doi:10.1186/1476-4598-2-23 · Cited by 224
Small Interfering RNAs: A Revolutionary Tool for the Analysis of Gene Function and Gene Therapy
Tuschl, T. (2002) · Molecular Interventions · doi:10.1124/mi.2.3.158 · Cited by 185
HIF-1: master and commander of the hypoxic world
Mazure, N. M., Brahimi-Horn, M. C., Berta, M., Benizri, E. I., Bilton, R. L., Dayan, F., Ginouvès, A., Berra, E., & Pouysségur, J. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.04.022 · Cited by 181
Chen, J., Zhao, S., Nakada, K., Kuge, Y., Tamaki, N., Okada, F., Wang, J., Shindo, M., Higashino, F., Takeda, K., et al. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63924-7 · Cited by 170
Thottassery, J. V., Zambetti, G. P., Arimori, K., Schuetz, E. G., & Schuetz, J. D. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.11037 · Cited by 163
Frederiksen, L. J., Siemens, D. R., Heaton, J. P. W., Maxwell, L., ADAMS, M. A., & Graham, C. H. (2003) · The Journal of Urology · doi:10.1097/01.ju.0000081126.71235.e0 · Cited by 107
Oxygen-mediated Regulation of Tumor Cell Invasiveness
Postovit, L.-M. M., ADAMS, M. A., Lash, G. E., Heaton, J. P. W., & Graham, C. H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204529200 · Cited by 96
Gene Expression Profile in Interleukin-4-Stimulated Human Vascular Endothelial Cells
Lee, Y. W., Eum, S. Y., Chen, K. C., Hennig, B., & Toborek, M. (2004) · Molecular Medicine · doi:10.2119/2004-00024.lee · Cited by 88
Regulation of Gene Expression by the Hypoxia-Inducible Factors
Fedele, A. O. (2002) · Molecular Interventions · doi:10.1124/mi.2.4.229 · Cited by 87
Conti, C. J. (2002) · The Oncologist · doi:10.1634/theoncologist.7-suppl_3-4 · Cited by 25
Cited by
Mechanisms of Multidrug Resistance in Cancer
Gillet, J.-P., & Gottesman, M. M. (2010) · Methods in Molecular Biology · doi:10.1007/978-1-60761-416-6_4 · Cited by 685
Rohwer, N., & Cramer, T. (2011) · Drug Resistance Updates · doi:10.1016/j.drup.2011.03.001 · Cited by 608
Hypoxia-targeted drug delivery
Sharma, A., Arambula, J. F., Koo, S., Kumar, R., Singh, H., Sessler, J. L., & Kim, J. S. (2019) · Chemical Society Reviews · doi:10.1039/c8cs00304a · Cited by 542
Shukla, S. K., Purohit, V., Mehla, K., Gunda, V., Chaika, N. V., Vernucci, E., King, R. J., Abrego, J., Goode, G. D., Dasgupta, A., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.06.004 · Cited by 540
Erin, N., Grahovac, J., Brozovic, A., & Efferth, T. (2020) · Drug Resistance Updates · doi:10.1016/j.drup.2020.100715 · Cited by 527
Metadata
- Authors
- Song, X., Liu, X., Chi, W., Liu, Y., Wei, L., Wang, X., & Yu, J.
- Venue
- Cancer Chemotherapy and Pharmacology
- Published
- 2006-03-11
- Volume
- 58
- Issue
- 6
- Pages
- 776-784
- ISSN
- 0344-5704 (ISSN-L)
- 1432-0843
- OpenAlex
- W2021381932
- Cited by
- 258
- References
- 31
- FWCI
- 5.26
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.